121 related articles for article (PubMed ID: 31666350)
21. HMQ-T-F5 (1-(4-(2-aminoquinazolin-7-yl)phenyl)-3-(2‑bromo‑5- (trifluoromethoxy)phenyl) thiourea) suppress proliferation and migration of human cervical HeLa cells via inhibiting Wnt/β-catenin signaling pathway.
Dai B; Yang T; Shi X; Ma N; Kang Y; Zhang J; Zhang Y
Phytomedicine; 2018 Dec; 51():48-57. PubMed ID: 30466627
[TBL] [Abstract][Full Text] [Related]
22. Functional role of SGK3 in PI3K/Pten driven liver tumor development.
Cao H; Xu Z; Wang J; Cigliano A; Pilo MG; Ribback S; Zhang S; Qiao Y; Che L; Pascale RM; Calvisi DF; Chen X
BMC Cancer; 2019 Apr; 19(1):343. PubMed ID: 30975125
[TBL] [Abstract][Full Text] [Related]
23. Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex.
Jiang Y; Ren W; Wang W; Xia J; Gou L; Liu M; Wan Q; Zhou L; Weng Y; He T; Zhang Y
Oncol Rep; 2017 Nov; 38(5):2597-2606. PubMed ID: 29048651
[TBL] [Abstract][Full Text] [Related]
24. Mutation-Associated Phenotypic Heterogeneity in Novel and Canonical PIK3CA Helical and Kinase Domain Mutants.
Ghodsinia AA; Lego JMT; Garcia RL
Cells; 2020 Apr; 9(5):. PubMed ID: 32365913
[TBL] [Abstract][Full Text] [Related]
25. Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases.
Ippen FM; Grosch JK; Subramanian M; Kuter BM; Liederer BM; Plise EG; Mora JL; Nayyar N; Schmidt SP; Giobbie-Hurder A; Martinez-Lage M; Carter SL; Cahill DP; Wakimoto H; Brastianos PK
Neuro Oncol; 2019 Nov; 21(11):1401-1411. PubMed ID: 31173106
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids.
Riemer P; Rydenfelt M; Marks M; van Eunen K; Thedieck K; Herrmann BG; Blüthgen N; Sers C; Morkel M
J Cell Biol; 2017 Jun; 216(6):1567-1577. PubMed ID: 28442534
[TBL] [Abstract][Full Text] [Related]
27. [Activation of HIF-1α/β-catenin signal pathway leads to radioresistance of prostate cancer cells].
Luo Y; Li MC; Zhao JH; Han YL; Lin YH; Wang YX; Jiang YG; Lu Q; Lan L
Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(32):2552-2558. PubMed ID: 30220138
[No Abstract] [Full Text] [Related]
28. Activation of β-catenin by oncogenic PIK3CA and EGFR promotes resistance to glucose deprivation by inducing a strong antioxidant response.
Cardone L; Bardelli A; Avvedimento VE
PLoS One; 2012; 7(5):e37526. PubMed ID: 22662165
[TBL] [Abstract][Full Text] [Related]
29. Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells.
Kim HJ; Lee SY; Kim CY; Kim YH; Ju W; Kim SC
Oncotarget; 2017 Jan; 8(4):6608-6622. PubMed ID: 28036259
[TBL] [Abstract][Full Text] [Related]
30. PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity.
Croessmann S; Wong HY; Zabransky DJ; Chu D; Rosen DM; Cidado J; Cochran RL; Dalton WB; Erlanger B; Cravero K; Button B; Kyker-Snowman K; Hurley PJ; Lauring J; Park BH
Breast Cancer Res Treat; 2017 Apr; 162(3):451-464. PubMed ID: 28190247
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Wnt signalling pathway by XAV939 enhances radiosensitivity in human cervical cancer HeLa cells.
Zhang J; Si J; Gan L; Guo M; Yan J; Chen Y; Wang F; Xie Y; Wang Y; Zhang H
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):479-487. PubMed ID: 31975621
[TBL] [Abstract][Full Text] [Related]
32. Response of head and neck squamous cell carcinoma cells carrying PIK3CA mutations to selected targeted therapies.
Wirtz ED; Hoshino D; Maldonado AT; Tyson DR; Weaver AM
JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):543-9. PubMed ID: 25855885
[TBL] [Abstract][Full Text] [Related]
33. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
[TBL] [Abstract][Full Text] [Related]
34. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the Genomic Landscape in Cervical Cancer by Next Generation Sequencing.
Qiu L; Feng H; Yu H; Li M; You Y; Zhu S; Yang W; Jiang H; Wu X
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205332
[TBL] [Abstract][Full Text] [Related]
36. The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the β-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt.
Regmi SC; Park SY; Kim SJ; Banskota S; Shah S; Kim DH; Kim JA
PLoS One; 2015; 10(11):e0141753. PubMed ID: 26544726
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-320 regulates the radiosensitivity of cervical cancer cells C33AR by targeting β-catenin.
Yang CX; Zhang SM; Li J; Yang B; Ouyang W; Mei ZJ; Chen J; Dai J; Ke S; Zhou FX; Zhou YF; Xie CH
Oncol Lett; 2016 Dec; 12(6):4983-4990. PubMed ID: 28105205
[TBL] [Abstract][Full Text] [Related]
38. Glycoprotein nonmetastatic melanoma protein B accelerates tumorigenesis of cervical cancer in vitro by regulating the Wnt/β-catenin pathway.
Xu S; Fan Y; Li D; Liu Y; Chen X
Braz J Med Biol Res; 2018 Nov; 52(1):e7567. PubMed ID: 30484490
[TBL] [Abstract][Full Text] [Related]
39. PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study.
Tzanikou E; Markou A; Politaki E; Koutsopoulos A; Psyrri A; Mavroudis D; Georgoulias V; Lianidou E
Mol Oncol; 2019 Dec; 13(12):2515-2530. PubMed ID: 31254443
[TBL] [Abstract][Full Text] [Related]
40. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer.
Li L; Yang WT; Zheng PS; Liu XF
Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
